Erika Santos Horta, MD

Full Member

Research Program:

Cancer Therapeutics

Faculty Rank:

Assistant Research Professor

Campus:

University of Arkansas for Medical Sciences

College:

College of Medicine

Department:

Neurology

Cancer Research Interest

Disease Site Focus: Brain
Research Focus Area: Treatment, Diagnosis/ Prognosis
Type of Research: Clinical
Research Keywords: brain tumors, neurofibromatosis, gliomas, meningiomas, clinical trials
Research Interest Statement: My mission is to improve the care of patients with brain tumors through developing clinical trials, disseminating knowledge and by listening to my patients experiences.

“NRG-BN011 A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma” (NCT05095376)
“A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy” (NCT04762069)
“CLadribine tablets: Observational evaluation of effectIveness and patient-reported outcomes (PROs) in suboptimally Controlled patients previously taKing injectable disease-modifying drugs (DMDs) for relapsing forms of Multiple Sclerosis (RMS) (CLICK-MS)” (NCT03933215)

Children's Tumor Foundation – CTF-2022-12-002
“Adult NF Clinic Program Building Pilot Project”
Principal Investigator
07/01/22 – 06/30/24

Horta E, Burke-Smith C, Megna BW, [et al.]. Prevalence of cerebrovascular accidents in patients with ulcerative colitis in a single academic health system. Scientific reports. 2022 12(1):18668. PMID: 36333367. PMCID: PMC9636207.
Horta E, Bongiorno C, Ezzeddine M, Neil EC. Neurotoxicity of antibodies in cancer therapy: A review. Clinical neurology and neurosurgery. 2020 188:105566. PMID: 31731087.